首页/数据集/Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

NIAID Data Ecosystem2026-03-09 收录

结直肠癌治疗

化疗方案评估

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2184828 数据链接链接失效反馈

官方服务：

资源简介：

This study is designed to compare the efficacy and safety of two-weekly RAILIRI regimen with FOLFIRI regimen in the treatment of advanced colorectal cancer patients in the second-line setting.

应用场景：

创建时间：

2014-09-15

结直肠癌治疗

靶向药物疗效评估

Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without bevacizumab in treating patients who have advanced or metastatic colorectal cancer that has been pre

NIAID Data Ecosystem50

Supplementary Material for: Patient’s Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer

医学研究

结直肠癌治疗

Background/Aims: To investigate the relation between skeletal muscle measurements (muscle mass, radiation attenuation, and sarcopenic obesity), postoperative morbidity, and survival afte

DataCite Commons2020-08-29 更新50

S1.

药物靶点识别

结直肠癌治疗

The targets of six groups of the main drug component β- Elemene γ- Elemene and δ- Elemene in Elemene Liposome , as well as colorectal adenoma (CA), colorectal cancer (CC) and innate immunity (II)

Figshare2022-04-09 更新20

Extended pelvic resections for the treatment of locally advanced and recurrent anal canal and colorectal cancer: technical aspects and morbimortality predictors aftet 24 consecutive cases

结直肠癌治疗

结直肠手术并发症预测与预防

ABSTRACT Objective: to evaluate the profile of morbidity and mortality and its predictors related to extensive pelvic resections, including pelvic exenteration, to optimize the selection of patients a

Mendeley Data2024-06-25 更新50

A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)

结直肠癌治疗

药物剂量优化

Interventions: On Day 1, patients treated with FOLFIRI therapy received a 2-hour intravenous infusion of CPT-11 (150 mg/m2) combined with 1-LV (200 mg/m2), followed by a rapid intravenous infusion of

NIAID Data Ecosystem30

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

资源简介：

相关数据集